MedTrace Logo

Piloting Pathways With Lung Cancer Patients

NCT04161157 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2023-10-05

Study results available
· View outcomes & findings →

Summary

The purpose of this research is to determine the feasibility of a new supportive intervention, called Pathways, for patients with advanced stage and metastatic lung cancer.

Conditions

  • Metastatic Lung Cancer

Interventions

BEHAVIORAL

Pathways

Goal-setting intervention to help patients identify personal values, value-consistent goals, and ways to pursue goals and address goal obstacles. Although potential refinements may occur based on aim 1 (refining procedures and content with 6 patients), Pathways is designed to consist primarily of 2 in-person sessions (\~30-60 minutes) delivered when patients are in clinic for cancer treatment, with supporting phone calls and contact in between sessions.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Laurie McLouth

    lead OTHER

Principal Investigators

  • Laurie McLouth, PhD · University of Kentucky

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-13
Primary Completion
2022-08-03
Completion
2022-08-03

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04161157 on ClinicalTrials.gov